Skip to main content
. 2015 Dec 2;6(40):42557–42568. doi: 10.18632/oncotarget.6449

Table 3. Differentially expressed miRNAs in the validation set determined using qRT-PCR (containing samples used in the selection phase).

Gene symbol Rank Parametric P-value HCs (n = 70) RA (n = 75) Fold-change
Up-regulated hsa-miR-4634 1 0.0118 10.01 4.358 2.297
hsa-miR-181d 2 0.0201 4.060 1.686 2.408
hsa-miR-4764-5 p 3 0.0299 15.12 29.69 1.964
Down-regulated hsa-miR-342-3p 1 0.0001 2.310 0.5078 0.2198
hsa-miR-3926 2 0.0001 6.891 1.182 0.1715
hsa-miR-3925-3p 3 0.0001 0.8896 0.04146 0.04661
hsa-miR-122-3p 4 0.0207 13.27 2.729 0.2057
hsa-miR-9-5p 5 0.0223 7.625 21.32 0.2796
hsa-miR-219-2-3p 6 0.0331 16.18 3.768 0.2329

Ranked by P-values generated from statistical comparisons between RA patients and HCs. In the RA and HCs columns, values for the mean of 2−Δcq for each group are listed. Fold-change is the ratio of relative expression of RA vs. HCs.